Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients

NCT02941913 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG: palonosetron

Sponsor

Instituto Nacional de Cancer, Brazil